USPTO serial 79115016
MOLECULAR CRO
Reviewed by CopyMark Law Group
Status 402
- Filing date
- Status date
- Registration date
- —
- Examiner
- AYALA, LOURDES
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MOLECULAR CRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | professional business consultation and business organization consultation in the market authorization of medicines and medical devices; planning and conducting of trade fairs for economic or advertising purposes; import-export agencies in the field of medicines and medical devices; wholesale store services and retail store services featuring medicines; business marketing services related to medicines and medical devices; commercial information and advice for consumers; wholesale store services in the chemical products sector; market reports and studies | SECTION 70 - CANCELLED | — |
| 042 | scientific and technological services, namely, scientific research, analysis and testing in the field of medicine, genetics and medical biomarkers; testing, analysis, and evaluation of medical diagnostic and biomarker preparations to assure compliance with industry standards; industrial chemical, biochemical, biological and bacteriological research and analysis; medical and scientific research information in the field of medicine, genetics and medical biomarkers; research and development of vaccines and medicines; design and testing for new product development, namely, pharmaceutical and diagnostic preparations and substances; development of pharmaceutical preparations and medicines; research and development of vaccines and medicines; testing, analyzing and evaluating new medicines; chemical research laboratories, pharmaceutical research laboratories, medical research laboratories, bacteriology research laboratories, molecular biological/biological research laboratories; medical and scientific research, namely, conducting clinical trials for others; scientific analyses in the field of chemistry, biology, molecular biology, pharmaceutics, and food technology; computer development of software in the field of the operation of therapeutic and diagnostic equipment and for the data processing for the purpose of imaging; scientific and technological services, namely, scientific research particular in the field of chemistry, genetics, biology, bioengineering, and biochemistry; chemical, biochemical, biological and bacteriological research and analysis; DNA and RNA analysis services, namely, development and research of DNA, RNA and scientific research in the field of biochemistry and biotechnology; scientific research; preparation of scientific opinions in the field of scientific research and development; advisory services relating to biotechnology, pharmaceutical research and development and genetic science; medical and scientific research, namely, the extraction or cultivation, scientific processing, and scientific analysis of biomaterials and compiling data for research purposes in the filed of medical science and medical consultancy; contract research in the field of pharmacological and clinical development of medicines; scientific data analysis for scientific and technical purposes, namely analysis of data originating from clinical trials; scientific laboratory services, namely, scientific development, research, identification, validation, analysis and interpretation of biomarkers, particularly nucleic acid based biomarkers | SECTION 70 - CANCELLED | — |
| 044 | medical services; veterinary services; hygienic and beauty care; medical diagnostic testing, monitoring and reporting services in preclinical and clinical settings; veterinary specialty services providing advanced medical and diagnostic services for animals; medical services, namely, medical and clinical examinations | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by febit holding GmbH
- Other trademarks owned by Comprehensive Biomarker Center GmbH
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MOLECULAR CRO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 4, 2022 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Sep 3, 2022 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jun 9, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 23, 2014 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 7, 2014 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 7, 2014 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 8, 2014 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 24, 2014 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 24, 2014 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 8, 2014 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 8, 2014 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 23, 2013 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Oct 7, 2013 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 7, 2013 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 22, 2013 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 22, 2013 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 7, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 6, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 6, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 30, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 9, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 9, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 9, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 8, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 3, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 2, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |